Oxford BioMedica plc  

(Public, LON:OXB)   Watch this stock  
Find more results for OXB
+0.25 (2.04%)
Apr 17 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 12.25 - 12.75
52 week 1.77 - 13.38
Open 12.50
Vol / Avg. 3.06M/10.23M
Mkt cap 314.54M*
P/E     -
Div/yield     -
EPS 0.00*
Shares 2.57B
Beta     -
Inst. own     -
Jun 16, 2015
Oxford BioMedica PLC Annual Shareholders Meeting (Estimated) - 10:00AM GMT+1 - Add to calendar
May 7, 2015
Oxford BioMedica PLC Annual Shareholders Meeting - 10:00AM GMT+1 - Add to calendar
Mar 9, 2015
Oxford BioMedica PLC at ROTH Conference

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -43.41% -63.60%
Operating margin -58.43% -77.93%
EBITD margin - -69.86%
Return on average assets -24.17% -36.51%
Return on average equity -32.53% -54.24%
Employees 113 -
CDP Score - -


The Oxford Science Park Medawar Centre Robert Robinson Avenue
United Kingdom - Map
+44-1865-783000 (Phone)
+44-1865-783001 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


Oxford Biomedica PLC is a United Kingdom-based biopharmaceutical company. The Company is engaged in advanced therapy medicinal products. The Company designs, develops and manufactures gene-based medicines and therapeutic vaccines. The Company's technology platform includes LentiVector gene delivery technology, which has specific advantages for targeting diseases of the eye and central nervous system and a tumour antigen (5T4), which is a target for anti-cancer therapy. Its product pipeline addresses diseases, including ocular diseases, neurodegenerative disorders and cancer.

Officers and directors

John Dawson Chief Executive Officer, Executive Director
Age: 54
Tim Watts Chief Financial Officer, Company Secretary, Executive Director
Age: 56
Peter Nolan Senior Vice President - Commercial Development, Executive Director
Age: 60
Paul Blake M.D. Chief Development Officer, Director
Age: 66
Nick Rodgers Non-Executive Independent Chairman of the Board
Age: 55
Andrew J. Heath M.D., Ph.D. Non-Executive Deputy Chairman of the Board, Senior Independent Director
Age: 64
Martin Diggle Non-Executive Director
Age: 52